These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 177905)

  • 1. The acetylcholine receptor in normal and pathologic states. Immunoperoxidase visualization of alpha-bungarotoxin binding at a light and electron-microscopic level.
    Bender AN; Ringel SP; Engel WK
    Neurology; 1976 May; 26(5):477-83. PubMed ID: 177905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural localization of acetylcholine receptor at the motor endplate: myasthenia gravis and other neuromuscular diseases.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Takamori M
    Neurology; 1980 Nov; 30(11):1203-11. PubMed ID: 7191515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
    Almon RR; Andrew CG; Appel SH
    Science; 1974 Oct; 186(4158):55-7. PubMed ID: 4421998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrajunctional acetylcholine receptors. Alterations in human and experimental neuromuscular diseases.
    Ringel SP; Bender AN; Engel WK
    Arch Neurol; 1976 Nov; 33(11):751-8. PubMed ID: 185992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sequential study of denervation - ultrastructural immunoperoxidase localization of alpha-bungarotoxin.
    Ringel SP; Bender AN; Engel WK; Daniels MP; Vogel Z
    Trans Am Neurol Assoc; 1975; 100():52-6. PubMed ID: 775726
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction.
    Bender AN; Ringel SP; Engel WK; Daniels MP; Vogel Z
    Lancet; 1975 Mar; 1(7907):607-9. PubMed ID: 47950
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoperoxidase localization of alpha bungarotoxin: a new approach to myasthenia gravis.
    Bender AN; Ringel SP; Engel WK; Vogel Z; Daniels MP
    Ann N Y Acad Sci; 1976; 274():20-30. PubMed ID: 60894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of acetylcholine receptors in the normal and denervated neuromuscular junction of the frog.
    Krause M; Wernig A
    J Neurocytol; 1985 Oct; 14(5):765-80. PubMed ID: 3879268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.
    Fambrough DM; Drachman DB; Satyamurti S
    Science; 1973 Oct; 182(4109):293-5. PubMed ID: 4742736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions.
    Stanley EF; Drachman DB
    Science; 1978 Jun; 200(4347):1285-7. PubMed ID: 663610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of myasthenic serum globulin with the acetylcholine receptor.
    Almon RR; Appel SH
    Biochim Biophys Acta; 1975 May; 393(1):66-77. PubMed ID: 1138925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine receptors.
    Green DP; Miledi R; Perez de la Mora M; Vincent A
    Philos Trans R Soc Lond B Biol Sci; 1975 Jun; 270(908):551-9. PubMed ID: 238250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine receptor and ion conductance modulator sites at the murine neuromuscular junction: evidence from specific toxin reactions.
    Albuquerque EX; Barnard EA; Chiu TH; Lapa AJ; Dolly JO; Jansson SE; Daly J; Witkop B
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):949-53. PubMed ID: 4351811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular junctions and alpha-bungarotoxin-binding sites in denervated and contralateral cat skeletal muscles.
    Steinbach JH
    J Physiol; 1981; 313():513-28. PubMed ID: 7277234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
    Reiness CG; Weinberg CB; Hall ZW
    Nature; 1978 Jul; 274(5666):68-70. PubMed ID: 661996
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denervation-related changes in acetylcholine receptor density and distribution in the rat flexor digitorum sublimis muscle.
    Guzzini M; Raffa S; Geuna S; Nicolino S; Torrisi MR; Tos P; Battiston B; Grassi F; Ferretti A
    Ital J Anat Embryol; 2008; 113(4):209-16. PubMed ID: 19507461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.